DBVT

Conviction 12HealthcareScan · Mon, Aug 10, 2026

Bullish engulfing

DBVT$14.26+5.75%

ResistanceSupportVol 14

Vol MA14 415.08K

May 11May 28Jun 16Jul 6Jul 23Aug 10

DBV Technologies S.A.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.dbv-technologies.com ↗

Price14.26

Change+5.75%

Gap-0.19%

Rel volume0.95×

Avg volume402.7K

Avg $ vol5.65M

SMA 2014.13

SMA 5015.62

SMA 20018.16

Price vs 50-8.73%

Price vs 200-21.52%

MA stackbearish

50/200 cross—

Supertrenddown · 15.66

RSI (14)47

MACD hist0.12

MACD crossbull · 4d

Stoch %K / %D75 / 49

ADX (14)22

+DI / −DI17 / 22

RSI divergence—

MACD divergence—

ATR %+6.11%

ADR %5.53%

52w high24.54

52w low8.70

From 52w high-41.91%

Above 52w low+63.85%

New 52w highNo

SqueezeOff

Bollinger width19.54%

%B0.55

Donchian pos33.96%

Donchian high16.70

Donchian low13.00

AVWAP (52w high)19.29

vs AVWAP high-26.11%

AVWAP (52w low)18.23

vs AVWAP low-21.80%

OBV trendDown

Chaikin MF (20)0.07

Today vs 20d0.95×

Avg vol (14d)415.08K

Avg vol (20d)402.7K

Avg $ vol (20d)5.65M

Market cap—

RS 3m (vs SPY)-38.26%

RS 6m (vs SPY)-51.30%

RS line new highNo

Trend template3/8

Technical rank14.0

1 week+4.97%

1 month-13.55%

3 months-27.75%

6 months-32.95%

1 year+45.88%

YTD-25.17%

P/E-27.24

P/B24.95

P/S710.21

P/FCF-32.89

EPS-1.05

Div yield—

ROE-91.61%

ROA-65.84%

Debt/Eq0.01

Current3.72

EV/EBITDA-26.58

Gross margin—

Net margin—

Rev growth35.77%

EPS growth-28.99%

Price target47.80

Target upside253.55%

Analyst ratingBuy

Institutional32.76%

Ent. value3.83B

Revenue700K

Net income-50.4M

Gross profit—

Free cash flow-121.71M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out59.21M

Employees161

ListedWed, Oct 22, 2014

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank14.0 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DBVT

All disclosures →

No recent disclosed trades by Congress in DBVT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DBVT

No recent insider (Form 4) filings in DBVT. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DBVT · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.